Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $53,569 - $63,151
102 Added 21.75%
571 $333 Million
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $10,432 - $14,383
-24 Reduced 4.87%
469 $252 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $172,914 - $231,207
493 New
493 $231 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kingdom Financial Group Llc. Portfolio

Follow Kingdom Financial Group Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdom Financial Group Llc., based on Form 13F filings with the SEC.

News

Stay updated on Kingdom Financial Group Llc. with notifications on news.